Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?

about

Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?

Item

http://www.wikidata.org/entity/Q35959266

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Transmission of human immunode ...... are the clinical implications?

@ast

Transmission of human immunode ...... are the clinical implications?

@en

type

Item

label

Transmission of human immunode ...... are the clinical implications?

@ast

Transmission of human immunode ...... are the clinical implications?

@en

prefLabel

Transmission of human immunode ...... are the clinical implications?

@ast

Transmission of human immunode ...... are the clinical implications?

@en

P1476

Transmission of human immunode ...... are the clinical implications?

@en

P2093

Anadol E

http://www.w3.org/2001/XMLSchema#string

Emmelkamp J

http://www.w3.org/2001/XMLSchema#string

Kaiser R

http://www.w3.org/2001/XMLSchema#string

Kupfer B

http://www.w3.org/2001/XMLSchema#string

Rockstroh JK

http://www.w3.org/2001/XMLSchema#string

Schwarze-Zander C

http://www.w3.org/2001/XMLSchema#string

Schülter E

http://www.w3.org/2001/XMLSchema#string

Verheyen J

http://www.w3.org/2001/XMLSchema#string

Wasmuth JC

http://www.w3.org/2001/XMLSchema#string

P2860

Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism

Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Epidemiology of antiretroviral drug resistance in drug-naïve persons.

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.

Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.

Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.

P2888

2047-783x-15-5-225

P304

225-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2047-783X-15-5-225

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44686694

http://www.w3.org/2001/XMLSchema#string

P6179

1004474448

http://www.w3.org/2001/XMLSchema#string

P698

20562063

http://www.w3.org/2001/XMLSchema#string

P932

3352013

http://www.w3.org/2001/XMLSchema#string